Kairos Venture Investments, Llc
Venture capitalBeverly Hills · Pre-Seed–Series A · 14 people tracked
Investment thesis
Kairos Ventures invests in ideas, patents, and businesses emerging from the world's top universities and scientists. The firm focuses on scientific and technology innovations with the potential to have a significant, world-changing impact. Led by a group of entrepreneurs with experience building diverse businesses, it positions itself at the intersection of leading financial, scientific, and entrepreneurial expertise, backing early-stage science-driven companies.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 8 of 32 portfolio companiesBiotech ×4AI & Machine Learning ×2Deep Tech ×2Healthtech ×2AgTech ×1Defense Tech ×1New Materials ×1Robotics ×1
HQs:United States×11
Investments · 32 tracked
founders shown can be your intro pathClinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.
BiotechFort Worth, US
Daniel Schmitt(Executive Officer, Director)Andrew Mazar(Executive Officer)Paul Lytle(Executive Officer)Leslie Wayne Kreis, Jr.(Director, Promoter)
BoardTodd Thomson(Director)Roger Sawhney(Director)
Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.
Culver City, US
Brian Stoltz(Director)Mark Attanasio(Director)David Chang(Director)David Licata(Director)Dennis Slamon(Director)
Develops radiation detection solutions for medical imaging, nuclear energy, and non-proliferation applications.
Develops patented technologies for metal manufacturing and material innovation that eliminate traditional machining processes.
Clinical-stage company developing non-invasive treatment for kidney stones affecting millions annually.
HealthtechSan Francisco, US
Paul Molloy(Executive Officer, Director)Gregory Johnstone(Executive Officer)Liu Chang(Director)John Garcia(Director)Ben Zadik(Executive Officer)Gordon Saul(Director)
Biopharmaceutical company harnessing the gut microbiome-central nervous system connection to develop novel therapeutics.
Provides emotion recognition and behavioral analytics technology that analyzes conversations to extract emotions and behavioral patterns.
Cloud-based, AI-enabled healthcare data analytics platform that transforms data into actionable insights with advisory services.
HealthtechJacksonville, US
Ken Misch(Chief Financial Officer and Chief Operating Officer)Jason Rose(Chief Executive Officer)Matt Henderson(Chief Compliance Officer and General Counsel)Jonathan Cook(Chief Technology Officer)Wirick Glenn(Chief Commercial Officer)Eugene Scheurer(Executive Officer, Director)
Biopharmaceutical company using molecular biology to produce recombinant derivatives of botulinum neurotoxin for customized applications.
BiotechNew York, US
Charles Weiss(Director)Andre Gudger(Director)Philip A. Band(Executive Officer, Director)Margery Fischbein(Director)
SaaS health tech platform using advanced data analytics to drive disease-specific, coordinated care pathways with streamlined workflows.
Develops next-generation drug delivery systems to improve clinical and commercial value of new and existing drugs.
Developed the first true wireless power transmission technology enabling previously impossible applications.
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
MattiQ accelerates materials science discovery using a platform for computational experimentation and design across energy, computing, transportation, and space industries.
AI & Machine LearningBiotechDeep TechNew MaterialsChicago, US
Chad A. Mirkin(Executive Officer, Director)Jeffrey Erhardt(Executive Officer, Director)Alex Andrianapoulis(Director)Louis Simpson(Director)
BoardQuinten Stevens(Director)Carmichael S. Roberts(Director)
Developing small, cost-effective infrared spectrometer for rapid chemical mixture analysis.
Multi-award-winning 5G mmWave chips offering breakthrough range and efficiency; acquired by Sivers Semiconductors in January 2022.
Chatham, US
Frank Anton Lane(Executive Officer, Director, Promoter)Harish Krishnaswamy(Executive Officer, Director, Promoter)
Provides nanotech coatings offering anti-fogging capabilities in consumer wearables and improved electronic display brightness.
Development-stage biopharmaceutical company focused on therapeutics for neurodegenerative disorders including Alzheimer's and Parkinson's.
Pioneering large-scale nano-architected materials production for diverse applications.
Early-stage ophthalmology company focused on treating ischemic eye diseases like age-related macular degeneration and diabetic retinopathy.
Develops integrated microfluidic technologies for dosing control in handheld vape products using patented breakthrough technologies.
PteroDynamics designs autonomous vertical takeoff and landing (VTOL) aircraft built around its patented Transwing folding-wing system, which combines fixed-wing speed and range with VTOL capability for delivering cargo and ISR payloads to remote locations without runways.
Defense TechRoboticsMoorpark, US
Matthew Graczyk(CEO)
Developing rapid, point-of-care diagnostic tool with single-molecule precision for identifying diverse analytes.
Develops technologies improving combustion and reacting flow processes for energy, aerospace, and defense applications.
Develops nanosecond pulsed power systems that increase fuel efficiency and reduce emissions significantly.
Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.
AI & Machine LearningBiotechDeep TechBrisbane, US
Julie O'Shaughnessy(Director)Andrei Georgescu(Executive Officer, Director)Quinten Stevens(Director)Alex Andrianopolous(Director)Dongeun Huh(Executive Officer, Director)ALEX ANDRIANOPOULOS(Director)
Revolutionizing the razor blade industry with proprietary Bulk Metal Glass technology in partnership with Kairos portfolio company Amorphology.
Exits · 2
IPOs and acquisitions across the tracked portfolioActuate TherapeuticsNASDAQ: ACTUMixCommacq. by Sivers Semiconductors
Portfolio news
latest coverage across their companiesMattiq · cen.acs.org · Nov 10, 2025
Vivodyne · pci.upenn.edu · Jul 8, 2025
Frequently asked questions
- What stage does Kairos Venture Investments, Llc invest at?
- Kairos Venture Investments, Llc invests at the Pre-Seed, Seed, Series A stages.
- What is Kairos Venture Investments, Llc's typical check size?
- Kairos Venture Investments, Llc typically writes checks of $150K – $20M.
- What sectors does Kairos Venture Investments, Llc focus on?
- Kairos Venture Investments, Llc focuses on Biotech, Deep Tech, Energy, Medical Devices, Mobility & Transportation, New Materials, Robotics, Sector Agnostic.
- Where is Kairos Venture Investments, Llc located?
- Kairos Venture Investments, Llc is headquartered in Beverly Hills, US.
- Does Kairos Venture Investments, Llc lead rounds?
- Yes, Kairos Venture Investments, Llc leads investment rounds.
Images
Similar investors
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.
Phoenix Venture Partners invests in early to revenue-stage companies tackling major challenges in computing, electronics, transportation, energy, industrial, and life sciences, offering hands-on support and access to a network of strategic partners.
Seafund is an early-stage venture capital firm that backs startups building in deeptech and deepscience, providing hands-on support alongside capital.